Administrable Passive Immunizing Agents 

This content is designed for use when populating a record at the point of administration and includes concepts represented by the trade name (brand name) of the passive immunizing agent (immune globulin or antitoxin) that was administered to the client. It consists of concepts from the Proprietary Medicinal Product class and from the SNOMED CT Pharmaceutical / biologic product hierarchy, that are described using their trade name (brand name). 

Scope Definition: 

The subset includes concepts represented by the trade name (brand name) of the passive immunizing agent (immune globulin or antitoxin) that was administered to the client. The scope of this subset is all passive immunizing agents that have been licensed for use in Canada, those obtained through special access programs for use in Canada, and those that were never licensed in Canada (i.e., administered in other countries). Passive immunizing agents are used to facilitate protection against vaccine preventable infections, when vaccines are not available or are contraindicated or when vaccines have not been used before exposure to the infective agent.

General rules applied to this section 

  • The passive immunizing agents trade names will be represented as found in the Health Canada Drug Product Database (DPD) : it may be a mix of capital and lower-case letters; The product monograph is a reference for validation of detailed information.  

Fully Specified Name 

The format for the Fully Specified Name (FSN) is as follows: 

  • Trade name (qualifier) Strength Dose Form Marketing Authorization Holder (MAH) (real clinical drug)  
    • E.g.: HepaGam B 312 international units per milliliter liquid for injection Cangene Corporation (real clinical drug) 

 FSN Components 

  • A qualifier may be added to FSN 

Preferred Synonym (English) 

For further details on PS, please refer to the Picklists guidelines.  

The format for the Preferred Synonym (PS) is as follows: 

  • [PHAC/CHI Abbreviation Product] Trade name (qualifier)(strength) (Marketing Authorization Holder (MAH) Abbreviation if required)  
    • e.g.: [HBIg] HepaGam B (STR) 

PS Components 

  • When adding a qualifier on the PS, it is not capitalized, unless otherwise represented in the product monograph. 

Preferred Synonym (French) 

  • La plupart des synonymes privilégiés en français sont les même qu’en anglais, à l’exceptions de certaines abréviations qui peuvent différer. 
  • Quand il n’a pas été possible de trouver une abréviation en français l’abréviation anglaise a été conservée.  
    • Par exemple : [CMVIg] Cytogam ou [BIG-IV] BabyBIG 



  • No labels